MYGN Myriad Genetics Inc

Myriad Genetics Inc is a molecular diagnostic company. It develops and markets novel predictive medicine, personalized medicine and prognostic medicine tests. It also provides physicians with information to solve unmet medical needs.

$25.68  +0.28 (1.10%)
As of 05/13/2021 15:59:55 EST     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Mid cap
GICS sector:  Health Care
Industry:  Diagnostics & Research
Index country:  USA
Country of incorporation:  USA
IPO date:  02/26/2001
Outstanding shares:  77,051,966
Average volume:  508,520
Market cap:   $2,011,826,832
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    62855J104
ISIN:        US62855J1043
Sedol:      2614153
Valuation   (See tab for details)
PE ratio:   -12.68
PB ratio:   2.23
PS ratio:   3.55
Return on equity:   -17.63%
Net income %:   -27.26%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy